HeraMED Ltd (ASX: HMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
HeraMED Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$8.39 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
279.51 million
Earnings per share
-0.016
Dividend per share
N/A
Year To Date Return
-76.80%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
HeraMED Ltd (ASX: HMD)
Latest News
Healthcare Shares
HeraMED (ASX:HMD) share price tanks despite US healthcare deal
HMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About HeraMED Ltd
HeraMED Ltd is engaged in developing innovative, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heart beat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart andconnected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR).
HMD Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 08 Dec 2023 | $0.03 | $-0.01 | -28.57% | 517,115 | $0.03 | $0.03 | $0.03 |
| 07 Dec 2023 | $0.04 | $0.00 | 0.00% | 163,291 | $0.04 | $0.04 | $0.04 |
| 06 Dec 2023 | $0.04 | $0.00 | 0.00% | 33,750 | $0.04 | $0.04 | $0.04 |
| 05 Dec 2023 | $0.04 | $0.00 | 0.00% | 20,000 | $0.04 | $0.04 | $0.04 |
| 04 Dec 2023 | $0.04 | $0.00 | 0.00% | 16,432 | $0.04 | $0.04 | $0.04 |
| 01 Dec 2023 | $0.04 | $0.00 | 0.00% | 32,920 | $0.04 | $0.04 | $0.04 |
| 30 Nov 2023 | $0.04 | $0.00 | 0.00% | 23,766 | $0.04 | $0.04 | $0.04 |
| 29 Nov 2023 | $0.04 | $0.00 | 0.00% | 46,829 | $0.04 | $0.04 | $0.04 |
| 28 Nov 2023 | $0.04 | $0.00 | 0.00% | 86,714 | $0.04 | $0.04 | $0.04 |
| 27 Nov 2023 | $0.04 | $0.00 | 0.00% | 50,000 | $0.04 | $0.04 | $0.04 |
| 24 Nov 2023 | $0.04 | $0.00 | 0.00% | 21,293 | $0.05 | $0.05 | $0.04 |
| 23 Nov 2023 | $0.04 | $-0.01 | -20.83% | 38,962 | $0.04 | $0.04 | $0.04 |
| 22 Nov 2023 | $0.05 | $0.00 | 0.00% | 30,833 | $0.05 | $0.05 | $0.05 |
| 21 Nov 2023 | $0.05 | $0.00 | 0.00% | 241,749 | $0.05 | $0.05 | $0.05 |
| 20 Nov 2023 | $0.05 | $0.00 | 0.00% | 429,833 | $0.05 | $0.05 | $0.05 |
| 17 Nov 2023 | $0.05 | $0.00 | 0.00% | 115,800 | $0.05 | $0.05 | $0.05 |
| 15 Nov 2023 | $0.05 | $-0.01 | -18.52% | 336,272 | $0.05 | $0.05 | $0.05 |
| 14 Nov 2023 | $0.05 | $0.00 | 0.00% | 8,555 | $0.05 | $0.05 | $0.05 |
| 13 Nov 2023 | $0.05 | $0.00 | 0.00% | 491 | $0.05 | $0.05 | $0.05 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 09 Oct 2023 | Ronald (Ron) Weinberger | Issued | 7,500,000 | $465,000 |
Issue of options.
|
| 23 Mar 2023 | Ronald (Ron) Weinberger | Buy | 215,000 | $24,553 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David Hinton | Non-Executive Director | Aug 2018 |
Mr Hinton has an career in the information and technology sectors and is currently Chief Financial Officer and Company Secretary of Empired Limited, an ASX listed IT and software services provider and prior to that Amcom Telecommunications Ltd. Mr Hinton is also a Director of Auspire - The Australia Day Council of Western Australia.
|
| Dr Ronald (Ron) Peter Weinberger | Executive Chairman | Nov 2023 |
Dr Weinberger is an experienced technology and business development executive, with a demonstrated history of building significant value at multiple levels in the medical device industry. During his time at Nanosonics, he co-developed their platform technology, launched their breakthrough product Trophon globally and created North American sales team to work alongside GE Healthcare. He also developed the distribution strategy for Europe having partnered with Toshiba Medical Systems (now Canon Medical Systems) and Miele Professional.
|
| Mr Doron Birger | Non-Executive Director | Oct 2018 |
Mr Birger is the former Chairman of Given Imaging (NASDAQ/TASE:GIVN), CEO of Elron electronic industries (Nasdaq/TASE: ELRN) and was a board member, during different periods, in a variety of publicly traded companies. During such period, he was involved in investments, merger and acquisitions, exits, public offerings on NASDAQ and TASE and private equity rounds totalling billions of dollars. Mr Birger currently serves as chairman and board member and consultant to a variety of technology companies, mainly in the medical device field, and conducts many voluntary and public activities. He was also Chairman of Medigus LTD and Insuline. He was also director of MCS MEDICAL, HBL Hadasit and Icecure.
|
| Ms Emily Slade | Non-Executive Director | Sep 2022 |
Ms Slade has experience across Legal and Business Affairs, Intellectual Property and Strategy, in a range of sectors including healthcare, logistics and technology. She has worked in a range of organisations from start-ups to SMEs as well as large public companies such as Ansell Limited. Emily was most recently Head of Legal and Business Affairs at Rendr, a fulfilment technology company providing on demand delivery solutions and was previously Head of Legal at Deliveroo AU and Legal Counsel Asia Pacific at Ansell Limited.
|
| Mr Jonathan Hart | Company Secretary | Mar 2020 |
-
|
| Sivan Sadan | Chief Financial Officer |
-
|
|
| Jonathan Hart | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Citicorp Nominees Pty Limited | 12,187,408 | 5.02% |
| Altshuler Shaham Trusts Ltd <Holley Pharma Co Ltd A/C> | 10,857,385 | 4.47% |
| Altor Capital Management Pty Ltd <Altor Alpha Fund A/C> | 10,628,875 | 4.38% |
| Freeman Road Pty Ltd <The Avenue A/C> | 10,543,779 | 4.35% |
| Altshuler Shaham Trusts Ltd <David Groberman A/C> | 9,709,170 | 4.00% |
| Altshuler Shaham Trusts Ltd <Tal Slonim A/C> | 9,709,170 | 4.00% |
| HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED | 8,294,621 | 3.42% |
| S & S Browne Assets Pty Ltd <S & S Browne Investment A/C> | 4,096,616 | 1.69% |
| Ratdog Pty Ltd | 3,670,000 | 1.51% |
| Bryntirion Capital | 3,637,273 | 1.50% |
| Ripperday Pty Ltd | 3,457,496 | 1.42% |
| Chris Ntoumenopoulos | 3,025,000 | 1.25% |
| Tamorer Pty Ltd <Wylie Family A/C> | 2,909,091 | 1.20% |
| Mayo Clinic | 2,767,691 | 1.14% |
| Mr Alan Jonathan Berrick | 2,552,273 | 1.05% |
| Dr Matthew Farrugia | 2,354,014 | 0.97% |
| Netwealth Investments Limited <Wrap Services A/C> | 2,171,276 | 0.89% |
| Cardup Syndicate Holdings Pty Ltd <The Cardup Syndicate A/C> | 2,050,000 | 0.84% |
| Mr John Vieira & Mrs Tracey Lois Vieira <Bayview Retirement Plan A/C> | 1,656,000 | 0.68% |
| Dr Stuart Lloyd Phillips & Mrs Fiona Jane Phillips <Sl & Fj Phillips Pension A/C> | 1,585,000 | 0.65% |
| North of the River Investments Pty Ltd | 1,508,042 | 0.62% |
